Synthetic Biology

As organ-on-a-chip technology comes of age, the bipartisan FDA Modernization Act 2.0 would remove the requirement that new drugs must undergo animal testing before human clinical trials.

Mini forests, seed preservation, our synthetic biology future, and a comic on depression.

Meat made from recycled carbon dioxide is on its way. But will it taste good?

An interview with MIT biologist David Sun Kong—on science, activism, and how biotechnology can empower ordinary people.

Demand from body builders, neonatal intensive care units, and Big Pharma fuels synbio substitutions for the goodness of breast milk.

We ask the experts what’s coming in the next 12 months.

Combining these two technologies can make CAR T cell therapy effective, accessible, and affordable for heart disease and cancer.

Regenerative medicine could get us there.

Pioneering synthetic biologist Pamela Silver drops some wisdom.

Within 10 years, archival data may be routinely stored in base pairs rather than bytes.